New Study From Health Equity Platform Violet and Octave Reveals 145% in Unlocked Inclusive Care Ability And Increased Health Outcomes Violet, the first health equity platform, released a new case ...
MENLO PARK, Calif.--(BUSINESS WIRE)-- Octave® Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, ...
Octave Bioscience, Inc., a company offering treatment for multiple sclerosis and other neurodegenerative diseases, said it will conduct a real-world study with its sponsor Biogen (Nasdaq: BIIB) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results